Basic Information
ID: ALA4177855
Type: Binding
Description: Inhibition of hepatitis B virus capsid assembly infected in human HepG2.215 cells assessed as reduction in viral DNA replication measured on day 7 by real time PCR analysis
Organism: Hepatitis B virus
Activity Charts
Bioactivity
Activity Types for Assay ALA4177855
EC50
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 287.22 | -0.05 | -0.05 |
| 273.19 | -0.44 | -0.44 |
| 242.23 | -1.51 | -1.51 |
| 395.77 | 3.69 | 3.69 |
| 365.82 | 3.47 | 3.47 |
| 509.40 | 3.29 | 3.29 |
| 446.96 | 3.04 | 3.04 |
| 509.40 | 3.29 | 3.29 |
| 506.60 | 4.19 | 4.19 |
| 539.43 | 3.29 | 3.29 |
| 503.37 | 3.22 | 3.22 |
| 510.39 | 2.68 | 2.68 |
| 464.95 | 3.18 | 3.18 |
| 508.41 | 3.89 | 3.89 |
| 481.40 | 3.69 | 3.69 |
| 506.38 | 2.56 | 2.56 |
| 493.34 | 1.88 | 1.88 |
| 351.79 | 3.39 | 3.39 |
| 509.40 | 3.29 | 3.29 |
| 507.39 | 4.18 | 4.18 |
| 457.51 | 2.29 | 2.29 |
| 508.35 | 1.58 | 1.58 |
| 407.90 | 4.64 | 4.64 |
| 423.90 | 3.88 | 3.88 |
| 481.02 | 3.89 | 3.89 |
| 395.84 | 2.84 | 2.84 |
| 507.36 | 1.96 | 1.96 |
| 365.82 | 2.29 | 2.29 |
| 394.86 | 2.80 | 2.80 |
| 448.50 | 2.66 | 2.66 |
| 536.63 | 4.20 | 4.20 |
| 430.51 | 2.52 | 2.52 |
| 462.98 | 4.33 | 4.33 |
| 365.82 | 3.47 | 3.47 |
| 478.98 | 3.52 | 3.52 |
| 497.02 | 2.91 | 2.91 |
| 574.60 | 5.21 | 5.21 |
| 491.41 | 3.15 | 3.15 |
| 409.87 | 3.49 | 3.49 |
| 393.87 | 4.25 | 4.25 |
| 539.35 | 3.50 | 3.50 |
| 524.42 | 2.99 | 2.99 |
| 350.81 | 2.79 | 2.79 |
| 438.91 | 2.43 | 2.43 |
| 494.33 | 1.27 | 1.27 |
| 379.84 | 3.86 | 3.86 |
| 437.92 | 4.27 | 4.27 |
| 364.83 | 3.05 | 3.05 |
| 513.02 | 2.57 | 2.57 |
| 453.92 | 3.51 | 3.51 |
| 463.97 | 2.75 | 2.75 |
| 295.30 | -0.83 | -0.83 |